Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
- 26 May 2021
- journal article
- other
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (8) , 740-745
Abstract
It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VVA) related to menopause. Equally, young women may temporarily present this clinical problem while receiving va...Keywords
This publication has 53 references indexed in Scilit:
- Assessment of sexual function and related factors in mid-aged sexually active Spanish women with the six-item Female Sex Function IndexMenopause, 2012
- EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophyMaturitas, 2012
- What is the evidence for the role of oestrogen in the prevention of recurrent urinary tract infections in postmenopausal women? An evidence-based reviewJournal of Clinical Gerontology and Geriatrics, 2010
- Vaginal microbiome of reproductive-age womenProceedings of the National Academy of Sciences, 2010
- Original Research—Outcomes Assessment: Development and Validation of a 6-Item Version of the Female Sexual Function Index (FSFI) as a Diagnostic Tool for Female Sexual DysfunctionThe Journal of Sexual Medicine, 2010
- Vulvovaginal AtrophyMayo Clinic Proceedings, 2010
- Validation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire DisorderThe Journal of Sexual Medicine, 2008
- Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosisAmerican Journal of Obstetrics and Gynecology, 2004
- ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinenceNeurourology and Urodynamics, 2004
- The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual FunctionJournal of Sex & Marital Therapy, 2000